Listed

SI-BONE, Inc.

SIBNNasdaqCIK 1459839HealthcareFiscal year ends Dec 31

Reports and events: 111 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

SI-BONE, Inc., Reports and events
FiledFormWhat it isAccession number
2026-09-1116:05 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001459839-26-000076
2026-08-0416:13 ET10-QQuarterly reportPeriod 2026-06-300001459839-26-000069
2026-08-0316:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-26-000066
2026-06-0816:09 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001459839-26-000059
2026-05-1117:03 ET10-QQuarterly reportPeriod 2026-03-310001459839-26-000056
2026-05-1116:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-26-000054
2026-04-2116:10 ETDEF 14AProxy statementPeriod 2025-12-310001459839-26-000049
2026-02-2416:19 ET10-KAnnual reportPeriod 2025-12-310001459839-26-000036
2026-02-2316:11 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors0001459839-26-000022
2026-01-1209:11 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001459839-26-000010
2025-11-1016:47 ET10-QQuarterly reportPeriod 2025-09-300001459839-25-000095
2025-11-1016:12 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001459839-25-000094
2025-08-0516:17 ET10-QQuarterly reportPeriod 2025-06-300001459839-25-000076
2025-08-0416:11 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001459839-25-000073
2025-06-0616:15 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001459839-25-000066
2025-05-0616:05 ET10-QQuarterly reportPeriod 2025-03-310001459839-25-000061
2025-05-0516:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-25-000059
2025-04-2516:08 ETDEF 14AProxy statementPeriod 2024-12-310001459839-25-000048
2025-02-2516:10 ET10-KAnnual reportPeriod 2024-12-310001459839-25-000036
2025-02-2416:27 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-25-000028
2025-01-1309:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-25-000005
2024-11-1217:00 ET10-QQuarterly reportPeriod 2024-09-300001459839-24-000077
2024-11-1216:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-24-000075
2024-08-0616:15 ET10-QQuarterly reportPeriod 2024-06-300001459839-24-000065
2024-08-0516:10 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001459839-24-000061
2024-07-1916:03 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001459839-24-000055
2024-06-2616:37 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001459839-24-000048
2024-05-0716:06 ET10-QQuarterly reportPeriod 2024-03-310001459839-24-000041
2024-05-0616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-24-000039
2024-04-2916:04 ETDEF 14AProxy statementPeriod 2023-12-310001459839-24-000031
2024-02-2716:03 ET10-KAnnual reportPeriod 2023-12-310001459839-24-000014
2024-02-2616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-24-000010
2024-01-0808:31 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001459839-24-000003
2023-11-0716:07 ET10-QQuarterly reportPeriod 2023-09-300001459839-23-000105
2023-11-0616:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-23-000102
2023-09-2016:04 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001459839-23-000095
2023-08-0816:08 ET10-QQuarterly reportPeriod 2023-06-300001459839-23-000091
2023-08-0716:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-23-000088
2023-06-1216:04 ET8-K5.07 Shareholder vote results0001459839-23-000083
2023-05-0819:56 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001459839-23-000080
2023-05-0216:24 ET10-QQuarterly reportPeriod 2023-03-310001459839-23-000063
2023-05-0116:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-23-000058
2023-04-2116:27 ETDEF 14AProxy statementPeriod 2023-04-210001459839-23-000036
2023-03-0216:11 ET10-KAnnual reportPeriod 2022-12-310001459839-23-000020
2023-02-2716:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-23-000014
2023-01-0909:04 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001459839-23-000003
2022-11-0816:07 ET10-QQuarterly reportPeriod 2022-09-300001459839-22-000044
2022-11-0716:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-22-000042
2022-08-0916:05 ET10-QQuarterly reportPeriod 2022-06-300001459839-22-000037
2022-08-0816:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001459839-22-000035

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:22 ET. Listed shows no prices and gives no investment advice.